Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tzamal Medical Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11512
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equipment, among others. It offers product developing for surgical, orthopedic, cardiovascular, neurology and ENT markets, among others. Tzamal Medical also provides products for the treatment of aesthetics and plastic surgery, dermatology and endovenous therapies. The company markets its products through its network of distributors across the US and Israel. It also partners with other pharma companies. Tzamal Medical is headquartered in Petah Tikvah, Israel.

Tzamal Medical Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 11
Licensing Agreements 12
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 12
Tzamal Medical Group Ltd – Key Competitors 13
Tzamal Medical Group Ltd – Key Employees 14
Tzamal Medical Group Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tzamal Medical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cardiome Pharma Enters Into Commercialization Agreement With Tzamal Medical For Brinavess 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 11
Tzamal Medical Enters into Licensing Agreement with Cardiome Pharma 12
Tzamal Medical Group Ltd, Key Competitors 13
Tzamal Medical Group Ltd, Key Employees 14
Tzamal Medical Group Ltd, Subsidiaries 15

List of Figures
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tzamal Medical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • Lepu Medical Technology (Beijing) Co Ltd (300003):医療機器:M&Aディール及び事業提携情報
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company that offers medical equipments, pharmaceutical products and healthcare services. The company’s products include cardiovascular interventional products, surgical cardiology products, peripheral interventio …
  • Alcon Inc (ALC):企業の財務・戦略的SWOT分析
    Alcon Inc (ALC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Consumers Energy Co (CMS PR B):石油・ガス:M&Aディール及び事業提携情報
    Summary Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates elec …
  • Ferrovial SA (FER):企業の財務・戦略的SWOT分析
    Ferrovial SA (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • SHV Holdings N.V.:企業の戦略・SWOT・財務情報
    SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary The Norwegian Radium Hospital Research Foundation (Radium Hospital) is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics and diagnostics. It operates as a hub for cancer and oncology treatment research. Radium Hospital …
  • Canacol Energy Ltd (CNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • Buck Institute for Research on Aging-製薬・医療分野:企業M&A・提携分析
    Summary Buck Institute for Research on Aging (Buck Institute) is a healthcare institute that conducts research and offers educational services. The institute concentrates on understanding the connection between aging and chronic disease. It works to understand how normal aging contributes to the dev …
  • Woodward Inc:企業の戦略・SWOT・財務情報
    Woodward Inc - Strategy, SWOT and Corporate Finance Report Summary Woodward Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • Georgia Power Co:企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • ACTIVE Network, LLC:企業のM&A・事業提携・投資動向
    ACTIVE Network, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ACTIVE Network, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Beach Energy Limited:企業の戦略・SWOT・財務情報
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southwestern Energy Co (SWN):企業の財務・戦略的SWOT分析
    Southwestern Energy Co (SWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BioMarin Pharmaceutical Inc.:企業の戦略・SWOT・財務情報
    BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cornell University-医療機器分野:企業M&A・提携分析
    Summary Cornell University (CU) is an educational institute that offers graduate and undergraduate education and research services. The institute offers education in biological and environmental engineering, communication, crop and soil sciences, development sociology, biological statistics and comp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆